202 related articles for article (PubMed ID: 9160765)
41. [Renal hemodynamics and proteinuria in chronic glomerulonephritis treated with beta-receptor blockers or ace inhibitors].
Erley CM; Berger ED; Heyne N; Klass M; Krämer D; Braun N; Wolf S; Risler T
Dtsch Med Wochenschr; 1997 Aug; 122(31-32):953-8. PubMed ID: 9280714
[TBL] [Abstract][Full Text] [Related]
42. The effect of converting enzyme inhibition on the enhanced proximal sodium reabsorption induced by chronic diuretic treatment in patients with essential hypertension.
van Schaik BA; Geyskes GG; Dorhout Mees EJ
Nephron; 1987; 47(3):167-72. PubMed ID: 2825050
[TBL] [Abstract][Full Text] [Related]
43. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
Esnault VL; Brown EA; Apetrei E; Bagon J; Calvo C; DeChatel R; Holdaas H; Krcmery S; Kobalava Z;
Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787
[TBL] [Abstract][Full Text] [Related]
44. Long-term renal effects of isradipine, a calcium entry blocker, in essential hypertension.
Persson B; Wysocki M; Andersson OK
J Cardiovasc Pharmacol; 1989 Jul; 14(1):22-4. PubMed ID: 2475710
[TBL] [Abstract][Full Text] [Related]
45. Effects of nitrendipine and cilazapril on renal hemodynamics and albuminuria in hypertensive patients with chronic renal failure.
Kloke HJ; Wetzels JF; van Hamersvelt HW; Koene RA; Kleinbloesem CH; Huysmans FT
J Cardiovasc Pharmacol; 1990 Dec; 16(6):924-30. PubMed ID: 1704985
[TBL] [Abstract][Full Text] [Related]
46. The persistent effect of long-term enalapril on pressure natriuresis in spontaneously hypertensive rats.
Dukacz SA; Adams MA; Kline RL
Am J Physiol; 1997 Jul; 273(1 Pt 2):F104-12. PubMed ID: 9249597
[TBL] [Abstract][Full Text] [Related]
47. Add-on angiotensin receptor blockade with maximized ACE inhibition.
Agarwal R
Kidney Int; 2001 Jun; 59(6):2282-9. PubMed ID: 11380832
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of antihypertensive effects of once-a-day isradipine and fosinopril: a double-blind crossover study by means of ambulatory blood pressure monitoring.
Perticone F; Pugliese F; Marcantonio AM; Cloro C; Maio R; Mattioli PL
Clin Cardiol; 1995 Jul; 18(7):401-7. PubMed ID: 7554545
[TBL] [Abstract][Full Text] [Related]
49. Renal and endocrine effects of long-term converting enzyme inhibition as compared with calcium antagonism in essential hypertension.
Katzman PL; Henningsen NC; Fagher B; Thulin T; Hulthén UL
J Cardiovasc Pharmacol; 1990 Mar; 15(3):360-4. PubMed ID: 1691357
[TBL] [Abstract][Full Text] [Related]
50. Angiotensin II receptor blocker and long-acting calcium channel blocker combination therapy decreases urinary albumin excretion while maintaining glomerular filtration rate.
Nakagawa N; Fujino T; Kabara M; Matsuki M; Chinda J; Kikuchi K; Hasebe N;
Hypertens Res; 2011 Oct; 34(10):1121-6. PubMed ID: 21796123
[TBL] [Abstract][Full Text] [Related]
51. Natriuretic response to neutral endopeptidase inhibition is blunted by enalapril in healthy men.
Motwani JG; Lang CC; Cramb G; Struthers AD
Hypertension; 1995 Apr; 25(4 Pt 1):637-42. PubMed ID: 7721409
[TBL] [Abstract][Full Text] [Related]
52. The effect of aprotinin (a serine protease inhibitor) on renal function and renin release.
Seto S; Kher V; Scicli AG; Beierwaltes WH; Carretero OA
Hypertension; 1983; 5(6):893-9. PubMed ID: 6197374
[TBL] [Abstract][Full Text] [Related]
53. Enalapril and the kidney: renal vasodilation and natriuresis due to the inhibition of angiotensin II formation.
Navis GJ; de Zeeuw D; de Jong PE
J Cardiovasc Pharmacol; 1986; 8 Suppl 1():S30-4. PubMed ID: 2422491
[TBL] [Abstract][Full Text] [Related]
54. Effects of nadolol on systemic and renal hemodynamics in patients with renoparenchymal hypertension and various degrees of renal function.
Valvo E; Gammaro L; Bedogna V; Cavaggioni M; Tonon M; Lupo A; Loschiavo C; Tessitore N; Oldrizzi L; Rugiu G
Int J Clin Pharmacol Ther Toxicol; 1986 Apr; 24(4):202-6. PubMed ID: 3710633
[TBL] [Abstract][Full Text] [Related]
55. Acute renal effects of felodipine in hypertensive patients with kidney disease.
Huysmans FT; van Hamersvelt HW; Sluiter HE; Wetzels JF; Koene RA
Kidney Int Suppl; 1992 May; 36():S106-9. PubMed ID: 1614059
[TBL] [Abstract][Full Text] [Related]
56. The angiotensin converting enzyme inhibitor enalapril and its effects on renal function.
de Zeeuw D; Navis GJ; Donker AJ; de Jong PE
J Hypertens Suppl; 1983 Oct; 1(1):93-7. PubMed ID: 6100614
[TBL] [Abstract][Full Text] [Related]
57. Changes in renal and systemic hemodynamics after NO-synthase inhibition in males with family history of hypertension.
Berger ED; Bader BD; Rüb N; Rauscher MA; Rebenschütz I; Gaber OC; Enderle MD; Risler T; Erley CM
Kidney Blood Press Res; 2002; 25(1):42-9. PubMed ID: 11834876
[TBL] [Abstract][Full Text] [Related]
58. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A
Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
[TBL] [Abstract][Full Text] [Related]
59. Daily oral sodium bicarbonate preserves glomerular filtration rate by slowing its decline in early hypertensive nephropathy.
Mahajan A; Simoni J; Sheather SJ; Broglio KR; Rajab MH; Wesson DE
Kidney Int; 2010 Aug; 78(3):303-9. PubMed ID: 20445497
[TBL] [Abstract][Full Text] [Related]
60. Calcium antagonism in essential hypertension: effect on renal haemodynamics and microalbuminuria.
Persson B; Andersson OK; Wysocki M; Hedner T; Karlberg B
J Intern Med; 1992 Mar; 231(3):247-52. PubMed ID: 1532613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
